Trxade Health Receivables

Trxade Health (MEDS) currently reports a receivables of $1.1B as of March 2026. That compares with $4M in the prior-year period — up 26244.5% year over year. Use the charts on this page to explore Trxade Health's receivables history and peer comparisons.

Trxade Health's receivables increased from $4M to $1.1B — a 26244.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trxade Health reported $1.1B in receivables as of March 2026. That compares with $4M in the prior-year period — up 26244.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Trxade Health, and consider following MEDS for alerts when major investors trade the stock.

Trxade Health is classified in the Finance sector. On receivables, it currently shows $1.1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing MEDS with unrelated industries.